The Prostate Cancer Charity has welcomed today's announcement by
the National Institute for Health and Clinical Excellence (NICE)
that they are to recommend abiraterone - the breakthrough treatment
for advanced prostate cancer - on the NHS in England and Wales, but
has vowed to continue campaigning until the drug is available on
the NHS for all men who need it throughout the UK.